USPTO serial 85202524
MITSUBISHI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 10, 2012
- Examiner
- BLANDU, FLORENTINA
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with MITSUBISHI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Chiyoda-ku, Tokyo, JP
Chiyoda-ku, Tokyo, JP
Chiyoda-ku, Tokyo, JP
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Industrial chemicals, namely, inorganic acids, alkalis, inorganic salts, hydrogen, helium, boron, carbon, nitrogen, oxygen, fluorine, neon, phosphorus, sulfur, chlorine, argon, arsenic, bromine, iodine, sodium, potassium and calcium all for use in the manufacture of chemical products including dyestuffs, fragrances, flavorings, pharmaceuticals, cosmetics; oxides, sulfides, carbides all for use in the manufacture of chemical products; water, namely, heavy water for use in nuclear reactors; distilled water; hydrocarbons, organic halogenides, alcohols, phenols, ethers, aldehydes and ketones, organic acids and their salts, esters, nitrogen compounds, heterocyclic compounds, carbohydrates, terpenes, tars and pitches, proteins and enzymes, organo-phosphorus compounds and organoarsenic compounds, organometallic compounds, surface-active agents, pastes and adhesives, all for use in the manufacture of paper and leather; photographic chemicals; industrial chemical preparations, namely, spinning agents, weaving agents, scouring agents, dyeing agents, wetting agents, ] antistatic agents [, water repelling agents, defoaming agents, foaming agents, defatting agents, decoloring agents, absorbents, anti-rust agents, mold releasing agents, flattening agents, stripping agents, rubber treating agents, filtering and clarifying agents, softening agents, fire proofing agents, water resisting agents, lagging agents, heating agents, anti-freeze agents, damp proofing agents, steel forging agents, casting and tempering agents, all for use in the manufacture of textile, metal and automobiles; refrigerant chemicals for air conditioning units; soldering flux; puncture proofing agents for tires; water proofing agents for building and construction surfaces; anti-sulphurizing agents for use in the manufacture of batteries; food preservatives; fuel economizing agents for motor vehicles; solvent type processing compositions for use in the oil field industry; agricultural fertilizers, catalyst agents for use in petrochemical plants and oil refineries; chemicals, namely, vulcanizing accelerators, anti-aging agents, pleating agents for clothes, anti-creasing agents and anti-shrink agents all for use in the manufacture of dry cleaning chemicals; plant fertilizer for agricultural use; coloring agents for use in the manufacture of pharmaceutical preparations; adhesives for use in the plastics industry; synthetic fragrances used in the manufacture of cosmetics; plant rearing agents and soil improvement agents for agricultural use; chemicals in the nature of excipients, ointment bases, solvents, flavoring and coloring agents, and deodorizers, all for use in the manufacture of pharmaceuticals; diagnostic reagents for research use ] | ACTIVE | — |
| 002 | [ Dyestuffs, namely, indigo, madder, logwood, cochineal, direct dyes, acid dyes, basic dyes, mordant dyes, sulfur dyes, vat dyes, naphthol dyes, rapid dyes, oil soluble dyes, alcohol soluble dyes, food colorants and fluorescent whitening dyes, all for use in the manufacture of textile, paper, pulp; color pigments, namely, white lead, titanium white, red lead, vermilion, ultramarine, prussian blue, lake; toner for printers and photocopiers; painting materials for interior and exterior use, namely, oil based paints, varnishes, enamels in the nature of house paint, lacquers in the nature of a coating, synthetic resin paints, water based paints, ship bottom paints, chemically resistant paints, anti-rust paints, fluorescent paints and wood stains; printing inks, namely, typographic inks, planographic inks and intaglio inks; natural resins for use in the manufacture of paper and leather ] | SECTION 8 - CANCELLED | — |
| 003 | [ Paint removers; shoe polishes; polishing agents, namely, leather polish, automobile body polish, floor polish, furniture polish and polishing oils for leather; non-medicated skin soaps, toilet soap, laundry soap, soap for industrial use; washing powders for hand and face; hair shampoos and hair-washing powders; dry cleaning fluids; cleansers and cleaning powders used to clean hands, ovens, pans, pots, sinks and tubs; dentifrices; cosmetics, namely, powders, toilet waters, creams and rouges, eye shadow; eyebrow pencils, mascara; hair cosmetics, namely, hair shampoo, hair conditioner, pomades, hair oil, hair creams, hair fixing oils and creams, combing oil, hair tonics, setting lotions, hair lacquers, permanent wave solutions, cold waving solutions, color rinses and hair dyeing preparations; perfumes; nail enamels; nail enamel removers; talcum powders; depilatories; non-medicated bath salts; skin moisturizers; baby powders; baby oils; personal fragrances in the nature of essential oils for personal use, namely, lavender oil, clove oil, peppermint oil, musk, ambergris and compound essences; essential oils for food flavorings; sachet powders; perfumed incenses and incense sticks; tin cleaners; medicated soap ] | SECTION 8 - CANCELLED | — |
| 005 | [ Pharmaceuticals relating to the central nervous system, namely, general anesthetics for surgical use, hypnotics and sedatives for use in the treatment of insomnia and somnipathy, anti-epileptics used to treat epilepsy, anti-pyretics and analgesics used to treat colds and headaches, nervous system stimulants and analeptics used to treat melancholia, and anti-dizziness agents used to treat meniere's disease; pharmaceuticals relating to the peripheral nervous system, namely, local anesthetics for surgical use in operations for spinal paralysis, skeletal muscle relaxants used to treat lumbago, autonomics used to treat amyosthenia, anti-spasmodics used to treat gastric ulcers; pharmaceuticals relating to the sensory organs, namely, ophthalmic use agents used to treat glaucoma, otorhinolar use agents used to treat tympanitis; pharmaceuticals relating to allergies, namely, anti-histamines used to treat urticaria and stimulation therapy agents used to treat rheumarthritis; pharmaceuticals relating to the circulatory organs, namely, cardiotonics used to treat stenocardia, arrhythmia treating agents used in operations for prophylaxis of arrhythmia, diuretics and hypotensors used to treat hypertension, vasoconstrictors used to treat hypotension involved in an anesthetic; anti-tussives and expectorants used to treat asthmatic bronchitis; pharmaceuticals relating to the digestive organs, namely, stomachics and digestives used to treat apepsia and esogastritis, antacids used to treat duodenal ulcers and gastric ulcers, anti-emetics used to treat prophylaxis of nausea of the stomach, choleretics used to treat cholangitis, antidiarrheals used to treat diarrhea and enteritis, purgatives and clysters used to treat constipation and to aid examination of the digestive system; dental use agents used to treat gingivitis and pyorrhea alveolaris; oral use agents used to treat pharyngolaryngitis; pharmaceuticals in the nature of pituitary hormone preparation used to treat dysadrenocorticism; pharmaceuticals in the nature of salivary gland hormone preparations used to treat bathygastry; pharmaceuticals in the nature of thyroid and parathyroid hormone preparations used to treat cretinism; pharmaceuticals in the nature of adrenal hormone preparations used to treat hemorrhagic shock, pharmaceuticals in the nature of androgens used to treat germinal aplasia; pharmaceuticals in the nature of estrogens used to treat a menstrual ovulation; pharmaceuticals in the nature of mixed hormone preparations used to treat menopausal syndrome; pharmaceuticals relating to the urinary, genital and anal organs, namely, urinary antiseptics used to treat cystitis, oxytocics used in abortions or cesarean operations; agents relating to epidermis, namely, disinfectants used to disinfect fingers, hands and arms, astringents and cataplasms used to treat dermatitis and sunburn, anti-dermoinfectives used to treat filarial dermotosis and corrosives used to treat keratoderma palmaris plantaris; vaccines for the treatment of cholera and influenza; toxins used to treat contact with or ingestion of poisons produced by plants, animals or bacteria, namely, viper toxin and botulinus toxin; toxoids used as an antigen to produce immunity to a specific bacterial toxin, namely, diphtheria toxoid and adsorbed tetanus toxoid; antitoxins injected into humans to prevent disease, namely, antibodies formed to act against an antigenic poison and as a serum containing an antitoxin, namely, bovine antitoxin and diphtheria antitoxin; diagnostic reagents for clinical and medical laboratory use, namely, x-ray contrast media used for taking an x-ray photograph of cerebral blood vessels, main arteries, or the bladder; diagnostic reagents for clinical and medical laboratory use, namely, for the examination of the capacity of the liver or kidney; medical diagnostic culture media for bacteriological examination purposes; anesthetic narcotics for non-surgical use, namely, opium alkaloids, derivatives and preparations and coca alkaloids, derivatives and preparations; veterinary pharmaceutical preparations for use in the treatment of distemper in livestock and poultry; agents for agriculture, namely, antivirus disinfectants, insecticides, fumigants, rodenticides, herbicides, germicides and hormones for plants; moth repellants; air deodorants; antiseptics; dental cements; fillings for teeth; medical oil papers, namely, waterproof oiled papers coated with purified linseed oil to be used in preventing seepage from externally and internally applied medical ointments; cotton swabs for medical use; oblates, namely, films made from starch and gelatin used as wrapping for assistance in the ingestion of powdered medicines; capsules of gelatin sold empty for filling with powdered medicine, used to assist the ingestion of powdered medicine; smelling salts; adhesive medical plasters; surgical bandages; ear bandages ] | SECTION 8 - CANCELLED | — |
| 010 | [ Eye patches for medical use; sanitary masks for use by medical personnel; abdominal belts; finger stalls for medical use; medical ice packs and suspenders therefor; cups adapted for feeding babies and children; enteral feeding appliances; ear implants in the nature of artificial tympanic membrane materials; prosthetic teeth; condoms; tweezers for medical use ] | SECTION 8 - CANCELLED | — |
| 030 | [ Food additives for non-nutritional purposes for use as a flavoring, ingredient or filler ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mitsubishi Shoji Kaisha, Ltd.
- Other trademarks owned by Mitsubishi Shoji Kaisha, Ltd.
- Other trademarks owned by Mitsubishi Shoji Kaisha, Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 002
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 030
- Similar marks named MITSUBISHI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 27, 2022 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Sep 27, 2022 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Sep 27, 2022 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Sep 15, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 22, 2022 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Apr 10, 2021 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Apr 15, 2018 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Apr 15, 2018 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Apr 15, 2018 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 5, 2018 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Apr 10, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 17, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 17, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 19, 2012 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Apr 10, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 24, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 24, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 4, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 17, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 13, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 13, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 13, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 13, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 13, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 17, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 9, 2011 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 7, 2011 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 26, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 26, 2011 | ALIE | ASSIGNED TO LIE | — |
| Oct 26, 2011 | ALIE | ASSIGNED TO LIE | — |
| Sep 29, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 23, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 23, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 23, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 29, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 24, 2010 | NWAP | NEW APPLICATION ENTERED | — |